Physician profile
Michael M Decker
NPI 1447525878
$55,696.41
in general payments reported to CMS, 2019-2025
12 companies · $37K in 2025
The $37K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $504 · 2021: $670 · 2022: $4,399 · 2023: $2,026 · 2024: $11K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $8,700 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Food and Beverage: $2,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,825.00 |
| Travel and Lodging | $8,699.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Food and Beverage | $2,607.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $49,182.22 | 2020-2025 | Real Intelligence, Journey II, Legion Revision |
| Stryker Corporation | $3,924.61 | 2019-2023 | Mako, Triathlon, Insignia |
| Zimmer Biomet Holdings, INC. | $1,432.48 | 2023-2025 | Rosa, Persona, Oxford |
| Orthalign INC | $306.00 | 2021-2023 | Orthalign Plus |
| Medtronic USA, INC. | $300.49 | 2020 | |
| Omnilife Science, INC | $252.81 | 2022 | |
| Linkbio Corp | $139.10 | 2024 | |
| Depuy Synthes Sales INC. | $112.58 | 2021-2022 | |
| Cerapedics INC. | $22.48 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Ferring Pharmaceuticals INC. | $11.87 | 2022 | |
| Orthofix Medical, INC. | $11.77 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.